DBV Technologies SA (DBVT)
19.50
-0.37
(-1.86%)
USD |
NASDAQ |
May 04, 16:00
19.50
0.00 (0.00%)
After-Hours: 20:00
DBV Technologies Enterprise Value : 919.54M for May 1, 2026
Enterprise Value Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Enterprise Value Definition
EV is considered the theoretical purchase ("takeover") price of a business because a purchaser would take on the company's debt, while pocketing the company's cash and gaining a right to all of the company's future earnings.
Enterprise Value Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Enterprise Value Benchmarks
| Cellectis SA | 308.57M |
| EDAP TMS SA | 137.29M |
| Akari Therapeutics Plc | 1.752M |
| Biodexa Pharmaceuticals Plc | -- |
| NuCana Plc | -22.34M |
Enterprise Value Related Metrics
| Net Income (Quarterly) | -44.80M |
| Total Expenses (Quarterly) | 44.80M |
| EPS Diluted (Quarterly) | -1.170 |
| Earnings Yield | -27.04% |
| Normalized Earnings Yield | -27.04 |